Representative before the EPO

Employment test 11 - 50 employees
Company dna reitstotter kinzebach and partner
operating since 1928
Headquarter in Munich, Berlin and 1 office
active in Legal Services

Thomas Wolter has worked on the following 2 EPO patent applications which have been published in the last five years:

EP13185422

Compositions monovalent for CD28 binding and methods of use

IPC classification:
C07K 16/28
Applicant:
Bristol-Myers Squibb Company
Agent:
Thomas Wolter, Reitstötter Kinzebach & Partner GbR
Status:
GRANT OF PATENT INTENDED
EP14802476

NMDA ANTAGONIST PRODRUGS

IPC classification:
A61K 31/4402, A61K 31/4439, A61P 25/24, C07D 213/40, C07D 401/12, C07D 401/14
Applicant:
AstraZeneca AB
Agent:
Thomas Wolter, Reitstötter Kinzebach & Partner GbR
Agent:
Diana Jean Pisani, Ropes & Gray International LLP
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature